The mechanism by which PARP inhibitors (PARPi) radiosensitized cancer cells involved converting sub-lethal single-strand DNA breaks (SSBs) into lethal double-strand DNA breaks (DSBs) during DNA replication, leading to the accumulation of DNA damage and ultimately cell death. Here, PARP1 is linked to cancer.